NandroloneNandrolone Decanoate (DECA) & Phenylpropionate (NPP) — Research Reference by QSC Peptides

Nandrolone (19-nortestosterone) is structurally identical to testosterone except for the absence of the C-19 methyl group. This single structural change has profound pharmacological consequences that make nandrolone one of the most-studied AAS compounds in the research literature.

Nandrolone binds AR with ~5× lower binding affinity than testosterone but maintains full agonist efficacy. Its anabolic activity in the levator ani assay is 125% of testosterone, while androgenic activity in prostate/seminal vesicle assays is only 37% — giving the 125:37 ratio.

Why the Androgenic Ratio is So Low — DHN vs DHT

In testosterone research, 5α-reductase converts testosterone to DHT (3–5× higher AR affinity), amplifying androgenic effects in skin/prostate/scalp. With nandrolone, 5α-reductase converts it to 5α-dihydronandrolone (DHN) — which has lower AR binding affinity than nandrolone itself. This 5α-reduction actually reduces androgenicity, explaining the dramatically low androgenic ratio.

Progestin Receptor Activity

Unlike testosterone, nandrolone has significant progestin receptor (PR) activity (~20% of progesterone). This distinguishes its pharmacology from pure AR agonists and is relevant in research on AR/PR cross-talk, mammary tissue biology, and gonadotropin suppression mechanisms.

Ester Options — DECA vs NPP

Nandrolone Decanoate (DECA, C10 ester): ~6–15 day half-life, stable blood levels for long-term research. Nandrolone Phenylpropionate (NPP, phenyl ring ester): ~4–5 day half-life, faster kinetics for short-term and pharmacokinetic studies. Both available from QSC Peptides at ≥99% purity.